Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2014 (99th)

A bill to require the National Drug Enforcement Policy Board to provide a comprehensive assessment of the designer drug problem and make recommendations to Congress for necessary legislation.

openUnited States· United States Congress· EN

Introduced

4 April 1985

Last action

27 October 1986 · Committee

Status

See H.R.5484.

Sponsors

Rep. Rangel, Charles B. [D-NY-15], Rep. Gilman, Benjamin A. [R-NY-20], Del. Fauntroy, Walter E. [D-DC-At Large], Rep. Smith, Lawrence [D-FL-16], Rep. Lagomarsino, Robert J. [R-CA-19], Sen. Akaka, Daniel K. [D-HI], Rep. Leland, Mickey [D-TX-18], Rep. Fascell, Dante B. [D-FL-19], Rep. Levine, Mel [D-CA-27], Rep. Edwards, Don [D-CA-10], Rep. Roe, Robert A. [D-NJ-8], Rep. Mitchell, Parren J. [D-MD-7], Rep. Mineta, Norman Y. [D-CA-15], Rep. Dornan, Robert K. [R-CA-46], Rep. Parris, Stanford E. (Stan) [R-VA-8], Rep. LaFalce, John J. [D-NY-29], Rep. Savage, Gus [D-IL-2], Rep. Torres, Esteban Edward [D-CA-34], Rep. Seiberling, John F. [D-OH-14], Rep. Murphy, Austin J. [D-PA-20], Rep. Matsui, Robert T. [D-CA-5], Rep. Wheat, Alan [D-MO-5], Sen. Boxer, Barbara [D-CA], Rep. Frost, Martin [D-TX-24], Rep. Rose, Charlie [D-NC-7], Sen. Mikulski, Barbara A. [D-MD], Rep. Fazio, Vic [D-CA-3], Rep. DioGuardi, Joseph J. [R-NY-20], Rep. Kaptur, Marcy [D-OH-9], Rep. Wortley, George C. [R-NY-27], Rep. Eckart, Dennis E. [D-OH-11], Rep. Williams, Pat [D-MT-At Large], Rep. Oakar, Mary Rose [D-OH-20], Rep. Vento, Bruce F. [D-MN-4], Rep. Ortiz, Solomon P. [D-TX-27], Rep. Young, C. W. Bill [R-FL-13], Rep. Dixon, Julian C. [D-CA-32], Rep. Bennett, Charles E. [D-FL-3], Rep. Foglietta, Thomas M. [D-PA-1], Rep. Crockett, George W., Jr. [D-MI-13], Rep. Heftel, Cecil [D-HI-1], Rep. Guarini, Frank J. [D-NJ-14], Rep. Scheuer, James H. [D-NY-8], Rep. Daub, Hal [R-NE-2], Rep. Hawkins, Augustus F. [D-CA-29], Rep. Dwyer, Bernard J. [D-NJ-6], Rep. DeLay, Tom [R-TX-22], Rep. Oxley, Michael G. [R-OH-4]

Subjects

Discovery layer

Source updated

30 June 2021

Official sourceView documentsShare

Summary

Requires the initial report of the National Drug Enforcement Policy Board to include: (1) a comprehensive assessment of the current and potential contribution of synthetic narcotic analogs (designer drugs) to the illegal narcotics problem in the United States; (2) proposals for illegal drug law enforcement strategies to prevent the manufacture and distribution of synthetic narcotic analogs; and (3) recommendations to the Congress for necessary legislation to eliminate the manufacture and distribution of illegal synthetic narcotic analogs.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 4 April 1985

    Introduced

    Referred to House Committee on The Judiciary.

    Source: IntroReferral

  2. 4 April 1985

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 4 April 1985

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 11 April 1985

    Referred

    Referred to Subcommittee on Crime.

    Source: Committee

  5. 1 May 1986

    Committee

    Subcommittee Hearings Held.

    Source: Committee

  6. 27 October 1986

    Committee

    See H.R.5484.

    Source: Committee

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 57 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.